OLD National Bancorp IN lessened its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 2.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 304,462 shares of the company's stock after selling 8,863 shares during the quarter. OLD National Bancorp IN owned about 0.14% of Bath & Body Works worth $11,804,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Hantz Financial Services Inc. bought a new position in shares of Bath & Body Works in the fourth quarter worth about $440,000. 1834 Investment Advisors Co. increased its position in Bath & Body Works by 5.5% during the 4th quarter. 1834 Investment Advisors Co. now owns 15,957 shares of the company's stock worth $619,000 after purchasing an additional 830 shares in the last quarter. Avior Wealth Management LLC lifted its stake in Bath & Body Works by 30.3% in the 4th quarter. Avior Wealth Management LLC now owns 1,950 shares of the company's stock valued at $76,000 after purchasing an additional 453 shares during the last quarter. Janney Montgomery Scott LLC acquired a new stake in Bath & Body Works in the fourth quarter valued at approximately $372,000. Finally, Missouri Trust & Investment Co boosted its holdings in shares of Bath & Body Works by 7.2% during the 4th quarter. Missouri Trust & Investment Co now owns 39,570 shares of the company's stock valued at $1,534,000 after acquiring an additional 2,660 shares in the last quarter. Institutional investors own 95.14% of the company's stock.
Bath & Body Works Price Performance
Shares of BBWI traded up $0.31 during trading hours on Monday, hitting $37.92. The stock had a trading volume of 1,705,884 shares, compared to its average volume of 2,923,442. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99. The firm has a market capitalization of $8.21 billion, a P/E ratio of 9.26, a price-to-earnings-growth ratio of 1.01 and a beta of 1.83. The firm has a 50 day simple moving average of $37.55 and a 200-day simple moving average of $33.61.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the previous year, the company posted $0.48 earnings per share. The company's quarterly revenue was up 3.1% on a year-over-year basis. Equities analysts predict that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.11%. Bath & Body Works's payout ratio is 19.51%.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on BBWI. JPMorgan Chase & Co. lifted their price target on Bath & Body Works from $39.00 to $41.00 and gave the company a "neutral" rating in a research note on Friday, January 24th. Piper Sandler boosted their target price on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a report on Monday, January 6th. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. Finally, TD Cowen lifted their target price on Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, December 12th. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $43.19.
Read Our Latest Analysis on BBWI
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Further Reading
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
